US8809340B2 - Crystalline form - Google Patents

Crystalline form Download PDF

Info

Publication number
US8809340B2
US8809340B2 US13/797,411 US201313797411A US8809340B2 US 8809340 B2 US8809340 B2 US 8809340B2 US 201313797411 A US201313797411 A US 201313797411A US 8809340 B2 US8809340 B2 US 8809340B2
Authority
US
United States
Prior art keywords
crystalline form
wo
ml
form
example
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US13/797,411
Other versions
US20130345239A1 (en
Inventor
Catherine Howsham
Christian Lindenberg
Anett Perlberg
Nicola TUFILLI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US201261612727P priority Critical
Application filed by Novartis AG filed Critical Novartis AG
Priority to US13/797,411 priority patent/US8809340B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NOVARTIS PHARMA AG
Assigned to NOVARTIS PHARMA AG reassignment NOVARTIS PHARMA AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PERLBERG, ANETT, TUFILLI, NICOLA, LINDENBERG, Christian
Assigned to NOVARTIS PHARMACEUTICALS UK LIMITED reassignment NOVARTIS PHARMACEUTICALS UK LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HOWSHAM, CATHERINE
Assigned to NOVARTIS AG reassignment NOVARTIS AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NOVARTIS PHARMACEUTICALS UK LIMITED
Publication of US20130345239A1 publication Critical patent/US20130345239A1/en
Publication of US8809340B2 publication Critical patent/US8809340B2/en
Application granted granted Critical
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links